Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.
One percent of circulating IgG in humans recognizes galactose alpha 1,3 galactose residues (anti-Gal) and is synthesized in response to stimulation by enteric bacteria. In this study, we found that the prevalence of binding of anti-Gal to blood isolates is significantly higher than its binding to no...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
1992
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442982/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1556184/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115706 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
